Dual GIPGLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 12, 19731985
The patients must be encouraged to follow the specific recommendations to avoid/mitigate diarrhoea (Table 2, Figure 1, Figure 2 and Figure 3), which should already have been taught to them as part of their education prior to GLP-1 RA initiation
However, were still very early in understanding who responds well and who doesnt
The theme may wear a crown, but your plan should hold the scepterguiding each click, each round, and each break with intention
Both platforms provide legitimate clinical oversight
For a head-to-head breakdown, our semaglutide vs tirzepatide comparison page lays out every meaningful difference